Evidence map›Paper›PMID 37444500›Full record

ArticleCancers2023

Higher Plasma Creatinine Is Associated with an Increased Risk of Death in Patients with Non-Metastatic Rectal but Not Colon Cancer: Results from an International Cohort Consortium.

Jennifer Ose, Biljana Gigic, Stefanie Brezina, Tengda Lin, Anita R Peoples, Pauline P Schobert, Andreas Baierl, Eline van Roekel, Nivonirina Robinot, Audrey Gicquiau and 15 more

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 6 countries.

Jennifer OseHuntsman Cancer Institute, Salt Lake City, UT 84112, USA.ORCID 0000-0002-2030-9676
Biljana GigicDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, 69117 Heidelberg, Germany.ORCID 0000-0002-8085-2072
Stefanie BrezinaInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, 23, 1090 Vienna, Austria.
Tengda LinHuntsman Cancer Institute, Salt Lake City, UT 84112, USA.
Anita R PeoplesHuntsman Cancer Institute, Salt Lake City, UT 84112, USA.
Pauline P SchobertHuntsman Cancer Institute, Salt Lake City, UT 84112, USA.ORCID 0009-0004-5717-0673
Andreas BaierlDepartment of Statistics and Operations Research, University of Vienna, 1, 1010 Wien, Austria.ORCID 0000-0002-5329-9507
Eline van RoekelDepartment of Epidemiology, GROW-School of Oncology and Developmental Biology, Maastricht University, 30, 6229 Maastricht, The Netherlands.ORCID 0000-0002-9402-2029
Nivonirina RobinotNutrition and Metabolism Branch, International Agency for Research on Cancer, WHO, 69366 Lyon, France.ORCID 0000-0002-2532-1455
Audrey GicquiauNutrition and Metabolism Branch, International Agency for Research on Cancer, WHO, 69366 Lyon, France.
David AchaintreNutrition and Metabolism Branch, International Agency for Research on Cancer, WHO, 69366 Lyon, France.
Augustin ScalbertNutrition and Metabolism Branch, International Agency for Research on Cancer, WHO, 69366 Lyon, France.ORCID 0000-0001-6651-6710
Fränzel J B van DuijnhovenDivision of Human Nutrition and Health, Wageningen University & Research, 6708 Wageningen, The Netherlands.
Andreana N HolowatyjHuntsman Cancer Institute, Salt Lake City, UT 84112, USA.ORCID 0000-0001-8001-8793
Tanja GumpenbergerInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, 23, 1090 Vienna, Austria.ORCID 0000-0001-9319-5350
Petra Schrotz-KingDivision of Preventive Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.ORCID 0000-0003-4339-3492
Alexis B UlrichDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, 69117 Heidelberg, Germany.
Arve UlvikBEVITAL, 87, 5021 Bergen, Norway.
Per-Magne UelandBEVITAL, 87, 5021 Bergen, Norway.
Matty P WeijenbergDepartment of Epidemiology, GROW-School of Oncology and Developmental Biology, Maastricht University, 30, 6229 Maastricht, The Netherlands.
Nina HabermannGenome Biology, European Molecular Biology Laboratory (EMBL), 69117 Heidelberg, Germany.
Pekka Keski-RahkonenNutrition and Metabolism Branch, International Agency for Research on Cancer, WHO, 69366 Lyon, France.ORCID 0000-0001-9437-3040
Andrea GsurInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, 23, 1090 Vienna, Austria.ORCID 0000-0002-9795-1528
Dieuwertje E KokDivision of Human Nutrition and Health, Wageningen University & Research, 6708 Wageningen, The Netherlands.ORCID 0000-0001-7154-8207
Cornelia M UlrichHuntsman Cancer Institute, Salt Lake City, UT 84112, USA.ORCID 0000-0001-7641-059X
Centre international de recherche sur le cancer · FRUniversity of Utah · USMedical University of Vienna · ATBevital (Norway) · NOHeidelberg University · DEMaastricht University · NLWageningen University & Research · NLEuropean Molecular Biology Laboratory · DEGerman Cancer Research Center · DEUniversity of Vienna · ATVanderbilt University · US

Funding

Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
Building Interdisciplinary Research Careers in Women's HealthK12HD043483 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTMANN, KATHERINE E, MAJOR, AMY S · 2002 to 2023
$10.3M
Discovery and verification of novel biomarkers of colorectal cancer recurrenceR01CA189184 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2015 to 2020
$5.6M
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer RecurrenceR01CA207371 · NCI · UNIVERSITY OF UTAH · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2017 to 2022
$3.9M
Building Interdisciplinary Research Careers in Women's HealthK12AR084232 · NIAMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI AMY S MAJOR, Digna R Velez Edwards · 2023 to 2026
$1.3M
Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIH-Consortium of Metabolomics Studies (COMETS)R03CA270473 · NCI · UNIVERSITY OF UTAH · PI PLAYDON, MARY CHRISTINE · 2022 to 2023
$151k
NCI NIH HHS R01CA189184NCI NIH HHS R01 CA207371NCI NIH HHS R01CA207371NCI NIH HHS R03CA270473NCI NIH HHS U01 CA206110NCI NIH HHS U01CA206110NIAMS NIH HHS K12 AR084232NICHD NIH HHS K12 HD043483World Health Organization 001
6 · The paper itself

Abstract

Colorectal cancer (CRC) is increasingly recognized as a heterogeneous disease. No studies have prospectively examined associations of blood metabolite concentrations with all-cause mortality in patients with colon and rectal cancer separately. Targeted metabolomics (Biocrates Absolute

Indexed as

all-cause mortalitycolon cancercreatininemetabolitesrectal cancerstarch and sucrose pathway

Identifiers

PMID37444500
PMCPMC10340258
OpenAlexW4382724478

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.